Skip to main content
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.


Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Table 2a. Therapeutic Management of Nonhospitalized Adults With COVID-19

Last Updated: April 20, 2023

Table 2a. Therapeutic Management of Nonhospitalized Adults With Mild to Moderate COVID-19 Who Do Not Require Supplemental Oxygen
Patient DispositionPanel’s Recommendations
All Patients
  • Symptom management should be initiated for all patients (AIII).
  • The Panel recommends against the use of dexamethasonea or other systemic corticosteroids in the absence of another indication (AIIb).
Patients Who Are at High Risk of Progressing to Severe COVID-19bPreferred therapies. Listed in order of preference:
  • Ritonavir-boosted nirmatrelvir (Paxlovid)c,d (AIIa)
  • Remdesivird,e (BIIa)
Alternative therapy. For use when the preferred therapies are not available, feasible to use, or clinically appropriate:
  • Molnupiravird,f,g (CIIa)
Each recommendation in the Guidelines receives a rating for the strength of the recommendation (A, B, or C) and a rating for the evidence that supports it (I, IIa, IIb, or III). See Guidelines Development for more information.